ArticleQuantitative biology (Beijing, China)2024
A substructure-aware graph neural network incorporating relation features for drug-drug interaction prediction.
Article in Quantitative biology (Beijing, China), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Computational approaches for drug-drug interaction prediction: a systematic review of data sources, modeling strategies, and evaluation frameworks.Frontiers in pharmacology · 2026Pooled it
- A substructure-aware graph neural network incorporating relation features for drug-drug interaction prediction.Quantitative biology (Beijing, China) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying drug-drug interactions (DDIs) is an important aspect of drug design research, and predicting DDIs serves as a crucial guarantee for avoiding potential adverse effects. Current substructure-based prediction methods still have some limitations: (i) The process of substructure extraction does not fully exploit the graph structure information of drugs, as it only evaluates the importance of different radius substructures from a single perspective. (ii) The process of constructing drug representations has overlooked the significant impact of relation embedding on optimizing drug representations. In this work, we propose a substructure-aware graph neural network incorporating relation features (RFSA-DDI) for DDI prediction, which introduces a directed message passing neural network with substructure attention mechanism based on graph self-adaptive pooling (GSP-DMPNN) and a substructure-aware interaction module incorporating relation features (RSAM). GSP-DMPNN utilizes graph self-adaptive pooling to comprehensively consider node features and local drug information for adaptive extraction of substructures. RSAM interacts drug features with relation representations to enhance their respective features individually, highlighting substructures that significantly impact predictions. RFSA-DDI is evaluated on two real-world datasets. Compared to existing methods, RFSA-DDI demonstrates certain advantages in both transductive and inductive settings, effectively handling the task of predicting DDIs for unseen drugs and exhibiting good generalization capability. The experimental results show that RFSA-DDI can effectively capture valuable structural information of drugs more accurately for DDI prediction, and provide more reliable assistance for potential DDIs detection in drug development and treatment stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.